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siRNA Knockdown of Tissue Inhibitor of
Metalloproteinase-1 in Keloid Fibroblasts Leads to
Degradation of Collagen Type I
Masayo Aoki1,2, Koichi Miyake1, Rei Ogawa2, Teruyuki Dohi1,2, Satoshi Akaishi2, Hiko Hyakusoku2 and
Takashi Shimada1
Keloids are defined as overgrowths of scar tissue resulting from abnormal wound healing. They are characterized
by excessive dermal deposition of thick, hyalinized collagen bundles resulting from an imbalance between the
production and degradation of extracellular matrix (ECM) components. Matrix metalloproteinases (MMPs) and
tissue inhibitors of metalloproteinases (TIMPs) are two important regulators of ECM degradation and remodeling.
To evaluate the role played by knockdown of TIMPs in keloid formation, we transduced human keloid–derived
fibroblasts (KFs) with small interfering RNAs targeting TIMP-1 or -2 (siTIMP-1 or siTIMP-2) using a lentiviral vector
and assessed the biological effects. We found that MMP-1/TIMP-1 and MMP-1/TIMP-2 complexes were
suppressed and that MMP-2 activity was upregulated in KFs expressing siTIMP-1 or siTIMP-2. In addition,
increased degradation of collagen type I was observed in the supernatant of KFs expressing siTIMP-1, but not
siTIMP-2, with the suppression of cell viability and induction of apoptosis. These results suggest that targeting
TIMP-1 using small interfering RNA has significant therapeutic potential as an approach to treating keloids
through degradation of their thick collagen bundles.
Journal of Investigative Dermatology (2014) 134, 818–826; doi:10.1038/jid.2013.396; published online 17 October 2013
INTRODUCTION
Keloids are defined as overgrowths of scar tissue that extend
beyond the area of the original skin injury in predisposed
individuals. They are thought to result from abnormal wound
healing (Marneros and Krieg, 2004), and a variety of factors,
including single-nucleotide polymorphisms (Nakashima et al.,
2010), mechanical forces (Ogawa et al., 2012), cytokines, and
growth factors, appear to be involved in their pathogenesis,
although the pathogenetic mechanism of keloid formation
remains unknown. Moreover, although many therapeutic
approaches have been used for keloids, they have proved
largely ineffective (Ogawa, 2010).
Histologically, keloids are characterized by excessive der-
mal deposition of thick, hyalinized collagen bundles, which
are the product of an imbalance between the production
and degradation of extracellular matrix (ECM) components
(Imaizumi et al., 2009). The major effectors of ECM degrada-
tion and remodeling belong to a family of structurally related
enzymes called matrix metalloproteinases (MMPs). In
mammals, the MMP family includes about 25 zinc- and
calcium-dependent proteinases. The subfamily of colla-
genases including MMP-1, -8, and -13 degrade native
fibrillar interstitial collagens by cleaving the single peptide
bond in a-chains, and this results in fragments of about 1/4
and 3/4 of the length of a complete molecule. Fibrillar colla-
gens can be destroyed only by these enzymes. The subfamily
of gelatinases including MMP-2 and -9 cleave type IV and
type V collagens, elastin, and denatured collagen (gelatin).
That is to say, gelatinases complement collagenases in the
degradation of fibrillar collagens (Khasigov et al., 2001).
Tissue inhibitors of metalloproteinases (TIMPs) are endo-
genous inhibitors of MMPs. The human genome contains
four paralogous genes encoding TIMP-1 to -4. Notably, the
relative levels of TIMP-1 and -2 expression are significantly
higher in both hypertrophic scars and keloids than in normo-
trophic scars, and the expression of TIMP-1 is significantly
higher in keloids than in hypertrophic scars (Ulrich et al.,
2010).
As a strategy for the treatment of keloids, we have been
investigating gene therapy using small interfering (si)RNAs
targeting TIMPs. It is thought that knocking down TIMPs in
keloid fibroblasts would enhance degradation of the excessive
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collagen bundles in keloid ECM. Furthermore, the accessibility
of skin and the ease with which it can be observed and
manipulated make the skin an excellent target for gene
transfer. Human immunodeficiency virus-1-based lentiviral
vectors are an ideal delivery mechanism for the long-term
therapeutic gene expression in dermal fibroblasts (Teo et al.,
2009). In the present study, we transduced human keloid–
derived fibroblasts (KFs) with lentiviral vectors encoding
TIMP-1 or -2 small interfering RNA (siRNA) and examined
their effects on TIMPs.
RESULTS
Suppression of TIMP-1 and -2 by siRNA
To analyze the effect of TIMP-1 and TIMP-2 in KFs, we
generated lentiviral vectors encoding siRNA targeting TIMP-1
or TIMP-2 (siTIMP-1A-C or siTIMP-2A-C, respectively),
(Supplementary Figure S1 online). To verify that these vectors
could be used to effectively knock down TIMP-1 and -2
expression patterns in the transduced KFs, we measured TIMP-
1/-2 messenger RNA and protein expression using quantitative
reverse transcriptase-PCR (qRT-PCR) and western blot, respec-
tively. Although transduction of LV-TH had no significant
effect on TIMP-1/-2 mRNA or protein expression, as compared
with untreated cells, expression levels of TIMP-1/-2 mRNA
and protein were reduced by 90% or more following trans-
duction with siTIMP-1/siTIMP-2 (Figure 1a and b). Similarly,
we confirmed that the expression of TIMP-1/-2 protein was
markedly reduced following transduction of normal fibroblasts
(NFs) with siTIMP-1/siTIMP-2 (Figure 1c).
To evaluate the specificity of the siRNAs used, we also
assessed the mRNA expression of TIMPs not targeted by a
given siRNA. We observed that the expression of TIMP-2
mRNA was reduced by 38 and 24% by siTIMP-1 A and C,
respectively, as compared with untreated cells, whereas the
expression of TIMP-1 mRNA was reduced by 27 and 13%
by siTIMP-2 B and C, respectively (Figure 1a). Because
siTIMP-1 B and siTIMP-2 A showed the strongest specificity
for their respective targets, we used these two vectors in
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Figure 1. Knockdown of tissue inhibitor of metalloproteinase (TIMP)-1 and -2 messenger RNA and protein expression using a lentiviral vector encoding
siRNA in keloid–derived fibroblasts (KFs). (a) Quantitative reverse transcriptase-PCR (qRT-PCR) analysis of TIMP-1/-2 mRNA levels in KFs 72 h after transduction
with 3 transduction units per cell of small interfering RNAs targeting TIMP (siTIMP)-1 (A–C), siTIMP-2 (A–C), or a non-targeting control vector (LV-TH). All values
were normalized to the level of an endogenous control (glyceraldehyde 3-phosphate dehydrogenase mRNA) in untreated control samples. Bars are means±SE of
five independent experiments (*Po0.0001 vs. untreated control samples, n¼ 5). (b) Western blot showing TIMP-1/-2 protein expression in KFs 72 h after
transduction. (c) Western blot showing TIMP-1/-2 protein expression in normal fibroblasts 72 h after transduction. (d) Transduction efficiency of siTIMP-1 B,
siTIMP-2 A, or a non-targeting control vector (LV-TH) in KFs; dot plots are representative (n¼ 18). GFP, green fluorescent protein; MW, molecular weight.
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subsequent experiments. The percentage of GFP-positive cells
after transduction was approximately 80%, that is, high and
stable transduction efficiency can be obtained, and there was
no significant difference between these vectors (Figure 1d).
Collagenase activity in culture medium conditioned by KFs
transduced with siTIMP-1/siTIMP-2
To investigate the effects of TIMP-1 or -2 knockdown on colla-
genase activity in ECM, we first used qRT-PCR to measure the
expression of MMP-1 mRNA. We found no significant TIMP-
related change in the expression of MMP-1 mRNA (Figure 2a).
Thereafter, to assess collagenase activity, we used specific
ELISAs to measure the concentrations of the MMP-1/TIMP-1
and MMP-1/TIMP-2 complexes in a KF-conditioned medium.
Secreted pro-MMPs are activated through the removal of their
propeptide domain. In the event that an active MMP enzyme
binds a TIMP protein, the C-terminal inhibitory domain of
TIMP occupies the space previously occupied by the removed
propeptide domain, thereby inactivating the enzyme (Nagase
and Woessner, 1999; Remacle et al., 2011). It is therefore
thought that reductions in the TIMP concentration in culture
supernatants are accompanied by corresponding increases in
active MMPs. We observed that the levels of MMP-1/TIMP-1
complex in the culture supernatants were 543±134 or
457±74 pg ml1 in samples from cells expressing LV-TH or
siTIMP-2, respectively, but the complex was barely detectable
in samples from cells expressing siTIMP-1 (Figure 2b, left).
Similarly, the levels of MMP-1/TIMP-2 complex were
610±104 or 476±142 pg ml 1 in culture supernatants from
cells expressing LV-TH or siTIMP-1, respectively, but no
complex was detected in medium from cells expressing
siTIMP-2 (Figure 2b, right). This suggests that the levels of
active MMP-1 were significantly increased by both siTIMP-1
and siTIMP-2.
Gelatinase activity in culture medium conditioned by KFs
transduced with siTIMP-1/siTIMP-2
Gelatinases also have an important role in collagen degrada-
tion within keloids, and the production of MMP-2 is reportedly
greater in KFs than in normal dermal fibroblasts (Fujiwara
et al., 2005; Yeh et al., 2009). Correspondingly, MMP-2 acti-
vity is significantly increased in hypertrophic scars and keloids
(Neely et al., 1999). When we used qRT-PCR to measure the
levels of MMP-2 mRNA expression, we detected no significant
TIMP-related difference in the expression pattern of MMP-2
mRNA (Figure 3a). We therefore used gelatin zymography of
conditioned medium to determine whether there were differ-
ences in the levels of gelatinase activity among the samples.
When samples containing 3–5mg of total protein were
applied, both pro-MMP-2 and active MMP-2 were detected
(no MMP-9 was detected), and active-MMP-2/pro-MMP-2
density ratios were significantly higher than control in the
medium conditioned by KFs expressing siTIMP-1 or siTIMP-2
(Figure 3b). When samples containing 30mg of total protein
were applied, no MMP-9 was detected in the medium
conditioned by untreated cells or cells transduced with
LV-TH.
Degradation of collagen type I in culture medium was promoted
by siTIMP-1 transduction
Collagen types I and III are the most abundant components
within the abnormal ECM deposits in keloids (Al-Attar et al.,
2006). To investigate the effects of TIMP-1/-2 knockdown in
KFs on ECM degradation, we first used qRT-PCR to confirm
that transducing KFs with siTIMP-1 had no significant effect
on the expression of collagen (COL)1A2 and COL3A1; in
contrast, the expression of COL1A2 and COL3A1 were
significantly higher in KFs transduced with siTIMP-2 than
those with LV-TH (Figure 4a). We also used an ELISA to
measure the concentration of collagen type I triple helix in
conditioned medium and found significant effects of TIMP-1
knockdown (Figure 4b). Collagenases cleave interstitial col-
lagens at a single site approximately three-quarters of the way
from the N-terminus of the triple helix, thus initiating colla-
genolysis (Manka et al., 2012). We therefore used western
blotting with type-specific antibodies to non-denatured three-
dimensional epitopes to examine the degradation of collagen
type I triple helix in conditioned medium. In samples from
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Figure 2. Interstitial collagenase (matrix metalloproteinase (MMP)-1) messenger RNA expression and activity in samples of the culture medium conditioned
by keloid–derived fibroblasts (KFs) transduced with lentiviral vector encoding tissue inhibitor of metalloproteinase (TIMP)-1 or -2 siRNA. (a) Quantitative
reverse transcriptase-PCR (qRT-PCR) analysis of MMP-1 mRNA levels in KFs 72 h after transduction with 3 transduction units per cell of siTIMP-1, siTIMP-2, or a
non-targeting control vector (LV-TH). All values are normalized to the level of glyceraldehyde 3-phosphate dehydrogenase mRNA in untreated control samples.
Bars are means±SE of six independent experiments (n¼ 6). (b) Levels of MMP-1/TIMP-1 and (c) MMP-1/TIMP-2 complexes detected by ELISAs in conditioned
medium 3–5 days after transduction. Bars are means±SE of four independent experiments (*Po0.05 vs. LV-TH, n¼4).
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siTIMP-1-expressing KFs, we observed a reduction in the
signal for 95 kDa, full-length collagen and increases in the
signals for several smaller molecular weights, which we
considered to be fragments of the degraded collagen type I
(Figure 4c), whereas these findings were not clear in samples
from siTIMP-1-expressing NFs. Among these fragments, we
focused on the signal near 30 kDa because it was observed in
all samples. We found that transducing KFs with siTIMP-1 led
to a sixfold increase in the degraded/full-length density ratios
(Figure 4d), whereas siTIMP-2 had no effect on collagenolysis.
We also confirmed these results using KFs transduced with the
other siTIMP-1/-2 vectors.
Suppression of cell viability and induction of apoptosis in KFs
transduced with siTIMP-1/siTIMP-2
TIMP-1/-2 exerts growth-promoting effects on many cell types,
including fibroblasts (Hayakawa et al., 1992, 1994). We
assessed the effects of siTIMP-1/-2 on NF/KF growth and
viability using fluorescence-activated cell sorting (FACS)
analysis and methyl thiazolyl tetrazolium (MTT) assays. We
found that KF viability was slightly, but significantly, reduced
by both siTIMP-1 and siTIMP-2 (Figure 5a). In addition,
annexin V assays showed that the fraction of annexin
V–positive (apoptotic) cells was significantly higher among
KFs transduced with siTIMP-1 and siTIMP-2 than that among
LV-TH transductants (Figure 5b and c). This is consistent with
an earlier report that TIMP-1 exerts anti-apoptotic effects in
various cell types (Murphy et al., 2002). In contrast, the
apoptotic cell fraction among NFs transduced with siTIMP-1
or siTIMP-2 did not significantly differ from the apoptotic
fraction among LV-TH-transduced NFs (Figure 5c). This
suggests that both TIMP-1 and -2 promote cell growth and
have anti-apoptotic activities within keloids.
To identify the mechanism of cell death, we performed cell
cycle analysis using FACS with propidium iodide–stained KFs
5 days after transduction. KFs transduced with siTIMP-1 or
siTIMP-2 showed an increase in the G2/M fraction (Figure 5d).
Mean percentages of G2/M phase cells were significantly
increased in samples of siTIMP-1 and siTIMP-2 transductants
(Figure 5e). This suggests that the small amount of growth
suppression induced by TIMP-1/-2 siRNA is likely attributable
to cell cycle arrest at G2/M phase.
Collagen bundles in keloid tissues transduced with siTIMP-1
show reduced thickness and complexity
To confirm the effectiveness of siTIMP-1 histologically,
we generated ex vivo cultures of keloid tissues transduced
with siTIMP-1/siTIMP-2. Subsequent immunostaining showed
that TIMP-1/TIMP-2 was suppressed in the cultured tissues
7 days after transduction (Figure 6a–f). Moreover, in keloid
tissues transduced with siTIMP-1, the thickness and com-
plexity of the collagen bundles were diminished, as compared
with tissues transduced with LV-TH, and the collagen
bundles were running parallel to the epidermis in a large
fraction of the dermis. In contrast, in specimens transduced
with siTIMP-2, the complexity of the collagen bundles was
similar to that in tissues transduced with LV-TH (Figure 6g–l).
These results substantiate those obtained in vitro, and the
degradative effect of siTIMP-1 on collagen was confirmed
histologically.
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Figure 3. Gelatinase A (matrix metalloproteinase (MMP)-2) messenger RNA expression and activity in the culture medium conditioned by keloid–derived
fibroblasts (KFs) transduced with lentiviral vector encoding tissue inhibitor of metalloproteinase (TIMP)-1 or -2 siRNA. (a) Quantitative reverse transcriptase-PCR
(qRT-PCR) analysis of MMP-2 mRNA levels in KFs 72 h after transduction with 3 transduction units per cell of siTIMP-1, siTIMP-2, or a non-targeting control vector
(LV-TH). All values are normalized to the level of endogenous glyceraldehyde 3-phosphate dehydrogenase mRNA in untreated control samples. Bars show
means±SE of four independent experiments (n¼4). (b) Gelatin zymography showing MMP-2 activity in conditioned medium 3–5 days after transduction. Two
representative gels are pictured. The graph shows active-MMP-2/pro-MMP-2 density ratios determined by densitometry. The bars are means±SD of four
independent experiments (*Po0.01 vs. LV-TH, n¼4).
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DISCUSSION
Contributing to the pathogenesis of keloids are both a genetic
predisposition and various local factors. Because the pathol-
ogy of this intractable ailment is not yet fully understood, there
is not yet a sufficiently effective treatment for keloids. Several
earlier reports on the in vitro effects of siRNA described the
targeting of Smad2, an intracellular effector of transforming
growth factor-b signaling (Gao et al., 2006), Smad3 (Wang
et al., 2007), vascular endothelial growth factor (Zhang et al.,
2008), and plasminogen activator inhibitor-1 (Tuan et al.,
2008). It is anticipated that siRNA therapy will bring a
significant advance in the treatment of keloids, and that
future development of siRNA preparations that can be
applied topically should greatly contribute to the treatment
of keloids.
In this report, both TIMP-1 and -2 siRNA efficiently and
specifically knocked down TIMP-1/-2 expression, which led to
significant increases in the activities of MMP-1 and -2. In
addition, an increase in the degradation of collagen type I was
observed with the transduction of siTIMP-1, indicating that the
siTIMP-1 might be a very interesting target for gene therapy of
keloids. In contrast, to our surprise, the expression levels of
COL1A2 and COL3A1 were significantly increased in trans-
ducing KFs with siTIMP-2. These results indicated that TIMP-2
has the effect of inhibiting the expression of collagens in
keloids. Although further studies are needed to understand the
mechanism of this collagen synthesis inhibitory effect of
TIMP-2, it is clear from our findings that there is a crucial
difference between the effects of TIMP-1 and -2 within
keloids.
TIMPs appear to have numerous effects in a wide variety
of tissues. On the basis of the data from TIMP knockout (KO)
mice, it appears that TIMP-1 is involved in regulating the
murine reproductive cycle, regulation of heart tissue remodel-
ing, regulation of feeding and energy balance, and learning
and memory function. TIMP-2 KO mice display various
phenotypes associated with defects in the central nervous
system and in myogenesis in relation to which the level of b1
integrin is altered (Brew and Nagase, 2010). It has also been
reported that MMP-2 activity is increased in TIMP-1 KO mice,
but that similarly enhanced MMP-2 activity is not observed in
TIMP-2 KO mice, which suggests only TIMP-2 is involved in
the pathway to MMP-2 activation (Wang and Soloway, 1999).
Moreover, a mechanism was proposed when TIMP-2 is
essential for MMP-2 activation by MT1-MMP (Toth et al.,
2000). In the present study, we observed that MMP-2 activity
was enhanced in TIMP-2 knockdown KFs showing an approxi-
mately 90% reduction in TIMP-2 expression. This suggests that
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Figure 4. Promotion of collagen type I degradation in culture medium conditioned by keloid–derived fibroblasts (KFs) transduced with lentiviral vector
encoding tissue inhibitor of metalloproteinase (TIMP)-1 siRNA. (a) Quantitative reverse transcriptase-PCR (qRT-PCR) analyses of collagen (COL)1A2 and
COL3A1 messenger RNA levels in KFs after transduction. All values are normalized to the level of glyceraldehyde 3-phosphate dehydrogenase mRNA in untreated
control samples. Bars show means±SE (*Po0.01, n¼ 4). (b) Collagen type I concentrations of conditioned medium determined by ELISA after transduction. Bars
are means±SD (*Po0.05, n¼ 3). (c) Western blot showing collagen type I in medium conditioned by normal fibroblast (NF)/KF transductants. (d) Collagen type I
degradation evaluated on the basis of quantification using western blot band densitometry of 95 kDa (full-length) and 30 kDa (degraded) collagen type I in the
medium conditioned by KFs. Bars are means±SD (*Po0.05, n¼ 3). MW, molecular weight.
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TIMP-2 inhibits the activation of MMP-2 in keloid and is not
consistent with the aforementioned effect seen in TIMP-2 KO
mice. Among their many functions are important roles in both
wound healing and tissue remodeling. TIMP-1 levels of dermis
early after surgery are lower than in those collected 2–4
months later (Blaha et al., 2012). Moreover, relative levels
of MMP-9 and TIMP-1 as well as MMP-9/TIMP-1 protein
ratios are decreased in diabetic mice (Bermudez et al., 2011).
Long-term TIMP-1 deficiency could potentially cause skin
atrophy or chronic skin ulcers (Vaalamo et al., 1996). An
appropriate dose and frequency of administration will need
to be determined to ensure that TIMP-1 is not excessively
suppressed.
For gene suppression in skin, topical delivery is the optimal
route of administration, given the easy accessibility of skin
and the smaller risk of systemic side effects. Penetration of
oligonucleotides through the epidermal barrier continues to be
a major technological challenge that must be overcome. In a
recent study, however, Zheng et al. (2012) showed spherical
nucleic acid nanoparticle conjugates (SNA-NCs) to be poten-
tially promising agents for personalized, topically delivered
gene therapy for skin disorders. If gene transfer could be
efficiently accomplished through topical delivery, a protocol
of regular transfers would be easy and large improvements,
or at least effective control, of the target ailment could be
expected, even for chronic diseases such as keloids. A key
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Figure 5. In vitro anti-proliferative, pro-apoptotic effects and G2/M phase cell cycle arrest induced by tissue inhibitor of metalloproteinase (TIMP)-1/-2
siRNA in keloid–derived fibroblasts (KFs). (a) A methyl thiazol tetrazolium (MTT) viability assay of normal fibroblasts (NFs)/KFs 3 days after transduction with
3 transduction units per cell of siTIMP-1, siTIMP-2, or a non-targeting control vector (LV-TH). All data are normalized to untreated control samples. Bars are
means±SD of four independent experiments (*Po0.05 vs. LV-TH, n¼ 4). Annexin V-APC apoptosis analysis of NFs/KFs 5 days after transduction; (b) dot plots are
representative of KFs. (c) Bars are means±SD of four independent experiments (*Po0.05 vs. LV-TH, n¼ 4). (d) PI cell cycle analysis of KFs 5 days after
transduction. Histograms are representative. (e) Bars are means±SD of four independent experiments (*Po0.05 vs. LV-TH, n¼ 4).
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obstacle to in vivo studies is the lack of animal models. In an
earlier study, human keloid explant models were applied
(Polo et al., 1998), but they have several disadvantages.
Recently, an animal model of keloids was reported in which
engineered skin substitutes composed of keloid-derived cells
were grafted into athymic mice (Supp et al., 2012). The
challenges of developing more efficient methods of gene
delivery with few systemic side effects remain, and long-
term observation in vivo will be needed to confirm the
therapeutic efficacy and safety of any approach.
In summary, we have demonstrated the effects of transdu-
cing KFs with siRNA targeting TIMP-1/-2. Our findings suggest
that TIMP-1 knockdown has significant therapeutic potential
as a gene therapy leading to the degradation of the thick
collagen bundles, characteristic of keloids. Because keloids
are histologically fibrotic lesions caused by excessive deposi-
tion of ECM, anti-fibrotic treatments are thought to be most
important. However, the pathogenesis of keloids is not yet
clear, and siRNA therapy that combines multiple targets may
be most effective. Although challenges remain to be overcome
before clinical application is possible, TIMP-1 appears to
be a promising target for the anticipated siRNA therapy for
keloids.
MATERIALS AND METHODS
siRNA duplexes and vector production
The targeting sequences for the siRNA duplexes were shown in
Supplementary Figure S1 online. pSUPER-siRNA constructs and pLV-
TH-siRNAs were generated as described previously (Brummelkamp
et al., 2002; Wiznerowicz and Trono, 2003). All recombinant
lentiviruses were produced by transient transfection of 293T cells as
described previously (Miyake et al., 2005). The biological titer of the
HIV vector was determined by transduction in HeLa cells and
counting the enhanced green fluorescent protein–positive cells
using FACS analysis. The titer of the final vector stock was approxi-
mately 1 109 transduction units (TU) ml 1.
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Figure 6. siTIMP-1 (small interfering RNAs targeting tissue inhibitor of metalloproteinase-1)-induced reductions in the complexity of collagen bundles in
ex vivo cultures of keloid tissues. Immunostaining of keloid tissues transduced with (a) LV-TH, (b) siTIMP-1, or (c) siTIMP-2 shows expression of TIMP-1 or TIMP-2
in cells expressing (d) LV-TH, (e) siTIMP-1, or (f) siTIMP-2. For each condition in (a–c) and (d–f), images were obtained at identical sensitivities. Hematoxylin
and eosin (H&E) staining of keloid tissues transduced with (g) LV-TH, (h) siTIMP-1, or (i) siTIMP-2. The asterisk indicates the area in which the complexity
of the collagen bundles was diminished, and the collagen bundles ran parallel to epidermis. (j–l) Higher magnification of the dermis in keloid tissues transduced
with (j) LV-TH, (k) siTIMP-1, or (l) siTIMP-2. Bar¼ 100mm.
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Cell culture and transduction with lentiviral vectors
Primary KF cultures were established as previously described
(Arakawa et al., 1990). For this study, KFs were used during
passages 2–4. Primary NFs were cultured from normal skin from
around the keloids removed during plastic surgery and were used
during passages 5–7. The cells were plated at 2 104 cells cm 2, and
after 24 h, recombinant lentiviral vectors (three multiplicity of infec-
tions) were added along with 8mg ml 1 polybrane (Sigma-Aldrich,
Milwaukee, WI). After incubation for 6–8 h, the medium was changed
to fresh culture medium. To analyze the production of collagens in
the supernatant or cells, ascorbic acid 2-phosphate (AA-2P) (Wako,
Japan) was added in the culture medium as previously described
(Kurata et al., 1993; Kivirikko and Myllyharju, 1998; Myllyharju,
2003; Chen and Raghunath, 2009). Three days later, the cells were
subjected to FACS analysis. When the enhanced green fluorescent
protein-positive cell fraction was greater than 70%, the following
analyses were performed. Each analysis was performed indepen-
dently using a different primary KF culture.
Quantitative real-time RT-PCR
Total RNA was extracted using RNeasy Mini Kits (Qiagen, Valencia,
CA) according to the manufacturer’s recommendations. cDNA was
then synthesized using High Capacity cDNA Reverse Transcription
Kits (Applied Biosystems, South San Francisco, CA). qRT-PCR was
performed using an ABI Prism 7500 System (Applied Biosystems) with
the RT2 SYBR Green/ROX PCR master mix (SA Biosciences, Freder-
ick, MD). For each primer set, the optimal dilution was determined,
and melting curves were used to determine the amplification
specificity. GAPDH served as the internal control. The primer pairs
used were shown in Supplementary Table S1 online. Relative
expression was calculated using the 2DDCt method with correction
for different amplification efficiencies.
Western blot and gelatin zymography
Cells (2 105) were seeded in the wells of a six-well plate and
transduced with lentiviral vectors. When analyzing collagens in the
supernatant or cells, AA-2P was added. Three days later, cells were
collected or incubated for an additional 48 h in serum-free DMEM
with AA-2P to obtain secreted ECM proteins. Aliquots of medium
were concentrated 60- to 80-fold using centrifugal filter units
(Millipore, Bedford, MA). Equal amounts of protein were separated
on a Mini Protean TGX gel (Bio-Rad, Hercules, CA) and transferred
to PVDF membranes. The antibodies used were as follows: polyclonal
anti-TIMP-1 (Cell Signaling Technology, Beverly, MA); polyclonal
anti-TIMP-2 (Abcam, Cambridge, MA); polyclonal anti-b-actin
(IMGENEX, SanDiego, CA); and horseradish peroxidase–conjugated
anti-rabbit IgG (GE Healthcare, Buckinghamshire, UK). To analyze
collagen type I, we used rabbit polyclonal anti-collagen I primary
antibody (ab34710, 1:5,000; Abcam). This is a type-specific anti-
body that reacts with non-denatured, three-dimensional epitopes
and recognizes the full-length protein. It shows little reactivity
against denatured collagen. The membranes were developed using
an ECL Prime Western blotting detection reagent (GE Healthcare). To
assess gelatinase activity, the concentrated medium were
subjected to gelatin zymography as described previously (Yaguchi
et al., 1998) using Gelatin Zymo Electrophoresis Kits (CosmoBio,
Japan). Densitometric analyses were performed using a CS Analyzer
(ATTO).
ELISA
The conditioned medium was collected for the detection of MMP-1/
TIMP-1 and MMP-1/TIMP-2 complex using a human MMP-1/TIMP-1
and MMP-1/TIMP-2 Complex DuoSet (R&D Systems, Minneapolis,
MN). In addition, the conditioned medium with AA-2P was collected
for the detection of collagen type I triple helix using Human Collagen
Type I ELISA kits (ACEL, Japan).
MTT assay
To assess cellular viability, MTT tests were performed as described
previously (Yacoub et al., 2003). Cells were plated (1.5 104 cells
per well of a 96-well plate) and transduced with lentiviral vectors.
Three days later, cellular viabilities were assessed using the CellTiter
96 Aqueous One Solution Reagent (Promega, Madison, WI)
according to the manufacture’s recommendations. Each assay was
performed in quadruplicate.
Apoptosis assay and cell cycle analysis
For apoptosis assay, the KF transductants were resuspended in
binding buffer containing Annexin V-APC and 7-AAD (BD Bio-
sciences, San Jose, CA), incubated according to the manufacturer’s
recommendations, and then quantified by FACS analysis using
Cellquest Pro. In addition, the KF transductants were fixed in cold
ethanol. The fixed cells were then stained for DNA using propidium
iodide (Invitrogen, Carlsbad, CA) as described previously (Sah et al.,
2004). The fraction of cells present in each cell cycle phase was
determined by the mathematical modeling of DNA histograms
representing 20,000 events or more using Modfit.
Ex vivo culture of keloid tissues, histopathology, and
immunohistochemistry
Ex vivo culture of keloid tissues were performed as described
previously (Yasuoka et al., 2008). The keloid tissue was cut into
10 10 mm sections, and lentiviral vector was injected intradermally
in a 100-ml volume (1 109 TU ml 1). Six hours after injection, the
specimens were cut into 5 5-mm-thick sections and incubated for
an additional 7 days. Keloid tissues were then fixed in 4%
paraformaldehyde. H&E staining was performed using standard
protocols. For immunohistochemical analysis, the sections were
first blocked with 1% bovine serum albumin and then incubated
with monoclonal antibody against TIMP-1 or TIMP-2 (Abcam),
washed, and incubated with secondary antibody (Alexa Fluor 546
Goat Anti-Mouse IgG, Invitrogen). Finally, the sections were
mounted using Vectashield with DAPI (Vector, Burlingame, CA)
and observed.
Statistical analysis
Statistical analyses were performed using Student’s t test to identify
differences between the groups. Values of Po0.05 were considered
significant.
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